AM 251 differentially effects food-maintained responding depending on food palatability

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 4, 2010, Pages 443-448

  Droste, Suzanne M ^a   Saland, Samantha K ^a   Schlitter, Emily K ^a   Rodefer, Joshua S ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

AM 251; Cannabinoid; Food intake; Food reinforcement; Motivation; Obesity; Progressive ratio schedule; Rat

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACAO; CONTROLLED STUDY; DOSE RESPONSE; DRUG SELECTIVITY; EATING DISORDER; FLAVOR; GRAIN; MALE; MOTIVATION; NONHUMAN; PALATABILITY; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMAL FEED; ANIMALS; APPETITE REGULATION; APPETITIVE BEHAVIOR; BEHAVIOR, ANIMAL; CACAO; CANNABINOIDS; CEREALS; CONDITIONING, OPERANT; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INVERSE AGONISM; FOOD PREFERENCES; MALE; MOTIVATION; OBESITY; PIPERIDINES; PYRAZOLES; RANDOM ALLOCATION; RATS; RATS, LONG-EVANS; RECEPTOR, CANNABINOID, CB1; REINFORCEMENT (PSYCHOLOGY); TASTE;

RATTUS;

EID: 77952544617     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.03.005     Document Type: Article

References (43)

1. Arnone M., Maruani J., Chaperon F., Thiebot M.H., Poncelet M., Soubrie P., et al. Selective inhibition of sucrose and ethanol intake by SR 141716A, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 1997, 132:104-106.
2. Budzynska B., Kruk M., Biala G. Effects of the cannabinoid CB1 receptor antagonist AM 251 on the reinstatement of nicotine-conditioned place preference by drug priming in rats. Pharmacol Rep 2009, 61:304-310.
3. Carroll M.E., Cosgrove K.P., Campbell U.C., Morgan A.D., Mickelberg J.L. Reductions in ethanol, phencyclidine, and food-maintained behavior by naltrexone pretreatment in monkeys is enhanced by open economic conditions. Psychopharmacology 2000, 148:412-422.
4. Chambers A.P., Koopmans H.S., Pittman Q.J., Sharkey K.A. AM 251 produces sustained reductions in food intake and body weight that are resistant to tolerance and conditioned taste aversion. Br J Pharmacol 2006, 147:109-116.
5. Colombo G., Agabio R., Diaz G., Lobina C., Reali R., Gessa G.L. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 1998, 63(8):PL113-PL117.
6. Cota D., Marsicano G., Lutz B., Vicennati V., Stalla G.K., Pasquali R., et al. Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord 2003, 27:289-301.
7. Di Chiara G., Acquas E., Tanda G., Cadoni C. Drugs of abuse: biochemical surrogates of specific aspects of natural reward?. Biochem Soc Symp 2003, 59:65-81.
8. Di Marzo V., Matias I. Endocannabinoids control of food intake and energy balance. Nat Neurosci 2005, 8:585-589.
9. Elamin E.M., Glass M., Camporesi E. Pharmacological approaches to ameliorating catabolic conditions. Curr Opin Clin Nutr Metab Care 2006, 9:449-454.
10. Escartín-Pérez E.E., Cendejas-Trejo N.M., Cruz-Martínez A.M., González-Hernández B., Mancilla-Díaz J.M., Florán-Garduño B. Role of cannabinoid CB1 receptors on macronutrient selection and satiety in rats. Physiol Behav 2009, 96:646-650.
11. Gaetani S., Kaye W.H., Cuomo V., Piomelli D. Role of endocannabinoids and their analogues in obesity and eating disorders. Eat Weight Disord 2008, 13:e42-e48.
12. Gaoni Y., Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964, 86:1646-1647.
13. Greenberg I., Kuehnle J., Mendelson J.H., Bernstein J.G. Effects of marijuana use on body weight and caloric intake in humans. Psychopharmacology (Berl) 1976, 49:79-84.
14. Halikas J.A., Weller R.A., Morse C.L., Hoffman R.G. A longitudinal study of marijuana effects. Int J Addiction 1985, 20:701-711.
15. Haney M., Gunderson E.W., Rabkin J., Hart C.L., Vosburg S.K., Comer S.D., et al. Dronabinol and marijuana in HIV-positive marijuana-smokers. Caloric intake, mood, and sleep. J Acquir Immune Defic Syndr 2007, 45:545-554.
16. Hao S., Avraham Y., Mechoulam R., Berry E.M. Low dose anandamine affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol 2000, 392:147-156.
17. Hodge J., Bow J.P., Plyler K.S., Vemuri K.V., Wisniecki A., Salamone J.D., et al. The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats. Behav Brain Res 2008, 193:298-305.
18. Hodos W. Progressive ratio as a measure of reward strength. Science 1961, 269:943-944.
19. Huang T.T.K., Glass T.A. Transforming research strategies for understanding and preventing obesity. J Amer Med Assoc 2008, 300:1811-1813.
20. Hursh S.R., Winger G. Normalized demand for drugs and other reinforcers. J Exp Anal Behav 1995, 64:373-384.
21. Maccioni P., Pes D., Carai M.A.M., Gessa G.L., Colombo G. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats. Behav Pharmacol 2008, 19:197-209.
22. Mathes C.M., Ferrara M., Rowland N.E. Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in novel dessert protocol in female rats. Am J Physiol Regul Integr Comp Physiol 2008, 295:R67-R75.
23. McLaughlin P.J., Winston K., Swezey L., Wisniecki A., Aberman J., Tardif D.J., et al. The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behav Pharmacol 2003, 14:583-588.
24. McLaughlin P.J., Winston K.M., Limebeer C.L., Parker L.A., Makriyannis A., Salamone J.D. The cannabinoid antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats. Psychopharmacology 2005, 180:286-293.
25. O'Neill C., Evers-Donnelly A., Nicoholson D., O'Boyle K.M., O'Conner J.J. D2 receptor-mediated inhibition of dopamine release in the rat striatum in vitro is modulated by CB1 receptors: studies using fast cyclic voltammetry. J Neurochem 2009, 108:545-551.
26. Pertwee R.G. Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci 2005, 76:1307-1324.
27. Pertwee R.G. The pharmacology of cannabinoid receptors and their ligands: an overview. Int J Obes 2006, 30:S13-S18.
28. Platt D.M., Rodefer J.S., Rowlett J.K., Spealman R.D. Suppression of cocaine- and food-maintained responding by the D2-like receptor partial agonist terguride in squirrel monkeys. Psychopharmacology 2003, 166:298-305.
29. Rasmussen E.B., Huskinson S.L. Effects of rimonabant on behavior maintained by progressive ratio schedules of sucrose reinforcement in obese Zucker (fa/fa) rats. Behav Pharmacol 2008, 19:735-742.
30. Richardson N.R., Roberts D.C. Progressive ratio schedules in drugs self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 1996, 66:1-11.
31. Rodefer J.S., Carroll M.E. Evaluation of the reinforcing efficacy of phencyclidine and ethanol under varied feeding conditions using progressive ratio schedules in rhesus monkeys. Psychopharmacology 1996, 128:265-273.
32. Rodefer J.S., Carroll M.E. A comparison of progressive ratio schedules versus behavioral economic measures: effect of an alternative reinforcer on the reinforcing efficacy of phencyclidine. Psychopharmacology 1997, 132:95-103.
33. Rodefer J.S., DeRoche K.K., Lynch W.A., Carroll M.E. A behavioral economic analysis of the effects of food deprivation and satiation on self-administration of phencyclidine and ethanol self-administration. Exp Clin Psychopharmacol 1996, 4:61-67.
34. Rodefer J.S., Campbell U.C., Cosgrove K.P., Carroll M.E. Naltrexone pretreatment decreases the reinforcing effectiveness of ethanol and saccharin but not PCP or food in rhesus monkeys under concurrent progressive-ratio schedules in rhesus monkeys. Psychopharmacology 1999, 141:436-446.
35. Salamone J.D., McLaughlin P.J., Sink K., Makriyannis A., Parker L.A. Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions. Physiol Behav 2007, 91:383-388.
36. Simiand J., Keane M., Keane P.E., Soubrie P. SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 1998, 9:179-181.
37. Sink K.S., Segovia K.N., Nunes E.J., Collins L.E., Vemuri V.K., Thakur G., et al. Intracerbroventricular administration of cannabinoid CB11 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats. Psychopharmacology 2009, 206:223-232.
38. Snedecor G.W., Cochran W.G. Statistical methods 1989, Iowa State University Press. Eighth Edition.
39. Sofia R.D., Knobloch L.C. Comparative effects of various naturally occurring cannabinoids on food, sucrose and water consumption by rats. Pharmacol Biochem Behav 1976, 4:591-599.
40. Tallet A.J., Blundell J.E., Rodgers R.J. Effects of acute low dose combined treatment with naloxone and AM 251 on food intake, feeding behavior and weight gain in rats. Pharmacol Biochem Behav 2008, 91:358-366.
41. Vickers S.P., Webster L.J., Wyatt A., Dourish C.T., Kennett G.A. Preferential effects of the cannabinoid CB-sub-1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology 2003, 167:103-111.
42. Ward S.J., Dykstra L.A. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940). Behav Pharmacol 2005, 16:381-388.
43. Xi Z.X., Spiller K., Pak A.C., Gilbert J., Dillon C., Li X., et al. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropsychopharmacology 2008, 33:1735-1745.